(S)-4-Hydroxy-2-(hydroxymethyl)-2-cyclopenten-1-one>90.0%(GC)50mg

7-{[(pyridin-2-yl)amino][4-(trifluoromethyl)phenyl]methyl}quinolin-8-ol, 97%, 500mg

1-Bromo-5-chloro-2-methyl-3-nitrobenzene, 95.0%, 25g

Hédéracoside C, min.90%, pour la biochimie, 250 mg, emballage en verre

Isoquinoline-7-carbonitrile, 95.0%, 1g

Hydroxyadamantanone, min.98%, pour la synthèse, 1 g, emballage en verre

1-(2-Pyridin-2-yl-ethyl)piperazine, 97.0%, 1g

1-(4-Bromobenzoyl)piperidine, 95.0%, 1g

3-BROMO-7-FLUORO-1H-INDAZOLE, 95%, 10g

3-Chlorosulfonyl-4-methylbenzoic acid, 95.0%, 25g

4-(2-Thienyl)phenol, 98%, 250mg

2-Iodo-5-methylpyridine, 95.0%, 250mg

Methyl (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate, 95%, 250mg